About Us
India's leading integrated API manufacturer.
Matrix Pharma Corp’s journey is defined by groundbreaking innovation, transformative partnerships, and an unwavering commitment to excellence. Since our inception, we have been at the forefront of Active Pharmaceutical Ingredient (API) manufacturing, earning the trust of leading pharmaceutical companies worldwide.
A defining chapter has been our leadership in the antiretroviral (ARV) space. As pioneers in ARV manufacturing, we have played a pivotal role in improving global access to affordable HIV treatments. Our journey has been shaped by transformative partnerships with Mylan, Viatris, and now, as Matrix Pharma Corp, we continue to champion advancements in this critical area.
Our purpose.
To enhance people's health and well-being, while spreading joy and fulfilment.
Our vision.
To be a time-tested, innovative global pharmaceutical company by empowering partners for enhancing lives.
Our values.
We believe true success is rooted in collective strength. We B 4 I (We Before I) reflects our commitment to a shared mindset – where collaboration, accountability, and a sense of belonging drive us forward.
Milestones
of excellence.
The partner of choice
for global leaders such as GSL, Bayer, and Sandoz, among others.
200+ patents
granted, 900+ patents filed.
$700 Mn+
in annual revenue.
64 million
lives touched by making ARV drugs affordable and accessible.
Zero-liquid discharge
and pharmaceutical waste recycling for a healthier planet.
EcoVadis
assessment completed.
Leadership Team
Anil Kumar Jain
Chief Executive Officer
Mr. Anil Kumar Jain joined Tianish Laboratories, a 100% subsidiary of Matrix Pharma Corp, as Chief Executive Officer in August 2024. With 36 years in the pharmaceutical industry, including 22 years in leadership roles, he brings extensive expertise in global operations, business transformation, and strategic growth.
Prior to Tianish, Mr. Jain led PI Health Sciences, spearheading multiple acquisitions across India, the EU, and the US. As CEO of Sun Pharma’s API business, he drove digital innovation, enhanced global operations, and established a strong ESG framework for sustainability. He also served as COO of Aurobindo Pharma, strengthening its global API business.
A Chemical Engineer with an Executive Leadership Program certification from IIM Bangalore, Mr. Jain is known for his pragmatic approach and visionary leadership.
Swathi Reddy Gunupati
Chief Corporate Officer
Swathi Reddy Gunupati is a dynamic entrepreneur and Chief Corporate Officer at Tianish Laboratories Private Limited. She leads corporate strategy, people, and culture initiatives, driving a workplace rooted in transparency, integrity, and employee empowerment through recognition, respect, and rewards.
Swathi is also the Founder of Mudhra Ventures, investing in early-stage startups. Her portfolio includes Pahadi Local, Dough Mama, and SeeSaw Spaces. She also produced the psychological thriller Mangalavaaram under Mudhra Media Works.
A Stanford University alumna specialising in Family Business Management and Women Entrepreneurship, she began her career at Sony Entertainment Singapore.
G. Pranav Reddy
Promoter Director
Mr. G. Pranav Reddy is a seasoned Executive and Promoter Director of Tianish Laboratories Private Limited. Tianish is recognised as a global leader in API manufacturing, and under his leadership in sourcing and financial strategy, the company continues to drive pharmaceutical innovation and excellence.
Beyond pharmaceuticals, he is an entrepreneur with ventures in infrastructure, real estate, hospitality, and aerospace. He leads GSR Ventures and RAPS, supplying advanced composites to India's DRDO and ISRO.
With a Bachelor’s in Finance and Business Management from Indiana University, Pranav’s strategic investments reflect his commitment to innovation.